Steve Tutewohl
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Steve Tutewohl
Earlier roles on record: COO at Evolent Health, Inc. (EVH) until July 3, 2023. Evolent Health, Inc. reported in an 8-K filed May 3, 2023 that Steve Tutewohl was terminated as Chief Operating Officer, effective July 3, 2023. The proxy statement of Evolent Health, Inc. reports total compensation of $2,374,018 for Steve Tutewohl in fiscal 2023, including a base salary of $233,333. Disclosed compensation is on record for 4 fiscal years.
“In connection with organizational restructuring, the Company is announcing the departure of Steve Tutewohl, Chief Operating Officer. Mr. Tutewohl's departure, effective July 3, 2023, will be treated as an involuntary termination without cause consistent with his existing severance and change-in-control agreement, a form of which was filed as Exhibit 10.32 to the Company's Annual Report on Form 10-K filed with the Securities and Exchange Commission (the "SEC"), on February 26, 2021.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
2020-06-30–2023-07-03
-
Start not stated–2023-07-03
Company network
Recorded roles and call appearances connecting this person to public companies.
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2023 | Evolent Health, Inc. (EVH) | Former Chief Operating Officer | $233,333 | $2,374,018 |
| 2022 | Evolent Health, Inc. (EVH) | Former Chief Operating Officer | $395,833 | $1,854,033 |
| 2021 | Evolent Health, Inc. (EVH) | Former Chief Operating Officer | $375,000 | $1,963,735 |
| 2020 | Evolent Health, Inc. (EVH) | Chief Operating Officer | $375,000 | $1,452,750 |
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.